| Founders & Directors
Paul R. Sanberg, Ph.D., D.Sc. - Chairman, Co-Founder
Dr. Sanberg is a co-inventor on all of Saneron's licensed technology. He has extensive experience in bringing neural transplantation therapies from the laboratory to the clinic. The companies are involved in cell therapy for degenerative disorders. He has also been on the Board of Directors for Medical Advisory Systems, Inc. (AMEX: DOC), and on numerous Scientific Advisory Boards for Companies and Foundations. His industry experience has included being Scientific Director for CytoTherapeutics, Inc., (Providence, Rhode Island), now Stem Cells, Inc., (Palo Alto, California) and was CSO and on the Board of Directors for Layton BioScience, Inc. (Atherton, California). Most recently, he co-founded, Nutritherapeutics, Inc. in order to develop natural products to promote healing. Dr. Paul R. Sanberg is Distinguished University Professor and Director of the Center of Excellence for Aging and Brain Repair and Associate Vice President/Associate Dean for Biotechnology Development at the University Of South Florida College Of Medicine. He trained at York University, the University of British Columbia, the Australian National University and at the Johns Hopkins University School of Medicine. Dr. Sanberg has held academic positions at the Ohio University, the University of Cincinnati, and Brown University prior to his current position. Dr. Sanberg is Editor-in-Chief of Cell Transplantation, Executive Director of the American Society for Neural Transplantation and Repair, and past president of the Cell Transplant Society, and others. He is the author of more than 400 scientific articles including thirteen books and is an inventor on over twenty U.S. patents. His early work was pioneering in understanding the role of cell death in neurological disorders.
Don F. Cameron, Ph.D. - Director, Co-Founder
Dr. Cameron is world renowned for his fundamental research in Sertoli cells and will be responsible for maintaining Saneron's competitive edge. He co- invented the use of Sertoli cells as a cellular therapy. His current NASA grant involves growing Sertoli cells and neurons together in microgravity, thus utilizing tissue engineering to create novel spheres of mixed cells ready for co-implantation. Dr. Cameron's industrial experience has included being CSO and Co-founder of Saneron Therapeutics, Inc., and founding scientist and scientific consultant for Theracell, Inc. He has also served as a consultant for Takada Pharmaceuticals North America, Inc. and the American Institute of Biological Sciences. In addition, Dr. Cameron is a Professor of Anatomy and has a joint appointment as a Professor of Neurosurgery at the University of South Florida. He is on the editorial board for the Journal of Andrology and Frontiers in Bioscience. He has served as chairman for the General Andrology meetings and Executive Council for the American Society of Andrology. Dr. Cameron has been awarded over 33 grants from institutions including National Institutes of Health, NASA, Bristol Drug Co., and the American Cancer Society. He has 12 U.S./Foreign patents, and over 70 publications.
Zubair Kazi - Director
Mr. Kazi is a highly successful entrepreneur possessing substantial knowledge and resources and is the owner of Kazi Food Corporation and KMVI, Inc. Kazi Foods Corporation is the second largest private operator of KFC Restaurants in the United States with over 180 restaurants. KMVI is a management consulting company based in St Thomas, USVI. His investment and business experience span a wide variety of industries operating nationally and internationally.
Daniel Richard - Founder
Daniel Richard has served as Chairman and CEO of Cryo-Cell International, Inc., a company he founded in 1989 and is the co-inventor of much of Cryo-Cell's technology. He founded CCEL Bio-Therapies, Inc. to conduct research on the umbilical cord blood being stored by Cryo-Cell. In addition, Mr. Richard was the first officer and director of Marrow-Tech, Inc. (now Advance Tissue Science, Inc.), a publicly traded company engaged in the field of cellular replication, and the inventor of the ever popular Entertainment Books.
Bernard R. Skerkowski, C.G.A. - Interim President and Corporate Treasurer
Mr. Skerkowski has over 22 years of accounting experience in both the private and public settings ranging from the Banking industry to Government Auditing and from Public Practice to Small Business Administration. He has been a Certified General Accountant since 1983 and operated his own private practice for the past 12 years. He has practiced in both the US and Canada and is a Certified Tax Advisor with the IRS.
Nicole Kuzmin-Nichols, M.B.A. - Senior Vice President, Corporate Development & Operations, Corporate Secretary
Ms. Kuzmin-Nichols has previous experience in biotechnology start-up management at ChanTest, Inc., serving as Director, Business Development & Operations and Corporate Treasurer. Under her direction, ChanTest, Inc. was able to i) increase sales over 600%, ii) expand staff 250%, and iii) graduate from the Lewis Incubator for Technology to a newly designed 7000 sq. ft. facility. Ms. Kuzmin-Nichols has nine years of research experience in biochemistry and molecular and cellular biology from Case Western Reserve University. She has served as a consultant for Cryobanks International, Inc., an NMDP-approved international cord blood bank and the Johnnie B. Byrd, Sr., Alzheimer's Center and Research Institute. She also serves as a consultant for Natura Therapeutics, Inc. and in memoriam int'l. Additionally, Ms. Kuzmin-Nichols is also a registered patent agent and has one U.S. patent application pending.
Cyndy Davis Sanberg, Ph.D. - Vice President, Research & Development
Dr. Sanberg has ten years of research experience in neurosurgery, neurobiology and neuropharmacology in a drug testing research laboratory at the University of Texas at San Antonio. She has served as director of the Saneron/USF cord blood bank for the past two years. She also has expertise in laboratory management (controlling a multimillion dollar budget), establishment of an online purchasing system, grant writing, and project and data management, as well as business operations. Dr. Sanberg also has experience in specialized patient care in a clinical setting. In addition, she has published several articles that involve human umbilical cord blood transplants for spinal cord injury, stroke, and ALS, and two U.S. patent applications pending. She has served as a consultant for Cryobanks International, Inc., a NMDP-approved international cord blood bank, and currently serves as Acting VP, Research for Naturatherapeutics, Inc. Dr. Sanberg also retains an academic appointment as an Affiliate Assistant Professor of Anatomy at USF.
Scientific Advisors & Collaborators
Samuel Saporta, Ph.D., Chair, Scientific Advisory Board
Paula Bickford, Ph.D.
Svitlana Garbuzova-Davis, Ph.D.
Walter Low, Ph.D.
Jacqueline Sagen, Ph.D., M.B.A.
Evan Snyder, M.D., Ph.D.
Alison Willing, Ph.D.
Copyright 2012 Saneron CCEL Therapeutics, Inc. All rights reserved.
Last updated April 2012